Related Experiment Videos
Altered cognitive functioning in children with idiopathic epilepsy receiving valproate monotherapy
S B Legarda1, M P Booth, E B Fennell
1Department of Pediatrics (Neurology), University of Florida, Gainesville, USA.
Insights
Valproate is a common epilepsy drug for children, but its cognitive effects require more research. New neuropsychological tests are needed to accurately assess these potential changes in pediatric patients.
Area of Science:
- Pediatric Neurology
- Neuropsychology
- Pharmacology
Background:
- Epilepsy in children can impact behavior and cognition.
- Antiepileptic drugs, including valproate, may also affect cognitive abilities.
- Limited research exists on valproate's specific cognitive effects in pediatric populations.
Purpose of the Study:
- To address the need for more conclusive data on valproate's cognitive effects in children.
- To highlight the inadequacy of generalizing adult study findings to pediatric patients.
- To propose a standardized neuropsychological test battery for assessing cognitive changes in children on anticonvulsant therapy.
Main Methods:
- Review of existing literature on cognitive effects of epilepsy and antiepileptic drugs in children.
- Identification of gaps in current research regarding valproate's impact on pediatric cognition.
- Proposal of a specialized test battery focusing on higher brain functions crucial for learning.
Main Results:
- Cognitive effects of valproate in children are not well-established.
- Adult data on valproate's cognitive effects cannot be directly applied to children.
- Current evidence on pediatric cognitive effects is inconclusive.
Conclusions:
- Further carefully designed studies are essential to determine valproate's cognitive effects in children.
- Neuropsychological measures sensitive to subtle cognitive changes are necessary.
- The proposed test battery aims to provide a robust method for assessing these changes.
Abstract:
Once a child is diagnosed with epilepsy, a primary concern is whether or not the child's behavior and cognitive abilities will be affected by the disease, by the drug prescribed for seizure control, or both. Direct cognitive effects by the epileptic condition have been described. On the other hand, cognitive effects in epilepsy have been attributed to antiepileptic drug therapy. Valproate is an antiepileptic drug of choice in managing the commonest childhood epilepsy syndromes. Although frequently prescribed in pediatric neurology practice, there have been relatively few studies investigating the cognitive effects of valproate therapy in children. Cognitive effects of valproate reported in normal adult volunteers and in adults with epilepsy cannot be generalized to the pediatric population. The results of investigations on children are less conclusive. Guidelines for antiepileptic drug trials in children have recently been formulated. Carefully designed studies are required in determining the cognitive effects of valproate in the pediatric population. Neuropsychological measures that are likely to assess subtle changes in higher brain functions crucial to learning in children should be employed. We propose a test battery to assess for cognitive changes associated with anticonvulsant therapy in children.